St. Jude Medical officials won't say outright that the pending medical-device tax is a job killer.
Business columnist Lee Schafer can't get St. Jude Medical officials or industry analysts to say outright that the pending medical-device tax is a job killer. Nevertheless, he's able to reach that conclusion ("St. Jude's job cuts are about device tax," Sept. 12). Yes, one analyst calls it "too big of a coincidence for it not to be a contributing factor" that expected annual savings from a company restructuring are similar to the projected cost of the 2.3 percent tax. But why not also consider lagging sales in the company's largest division or draw a comparison between the cuts and the company's last-quarter sales dip? Schafer calls it a 2 percent decline, while my calculator says 2.25 percent. Probably too small of a coincidence.
CHARLES QUIMBY, GOLDEN VALLEY
The Opinion section is produced by the Editorial Department to foster discussion about key issues. The Editorial Board represents the institutional voice of the Star Tribune and operates independently of the newsroom.